While our study demonstrates significant upregulation of FOS in MI patients and robust diagnostic performance (AUC > 0.8 in ROC analysis), its strong correlation with immune infiltration raises valid concerns about specificity as a standalone diagnostic biomarker. This evidence concerns the gene FOS and myocardial infarction.